Treatment-free Survival and Partitioned Survival Analysis of Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab Plus Ipilimumab Versus Sunitinib: 5-Year Update of CheckMate 214
JOURNAL FOR IMMUNOTHERAPY OF CANCER(2024)
Key words
Kidney Cancer
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined